| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 10/06/2010 | CN101849948A Cefuroxime axetil composite medicine |
| 10/06/2010 | CN101849919A N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same |
| 10/06/2010 | CN101279019B Bone-knitting medicine |
| 10/06/2010 | CN101259213B Health drug pillow |
| 10/06/2010 | CN101152178B Sophoridine nano liposome medicament and preparation of the same |
| 10/06/2010 | CN101147743B Application of ginsenoside Compound-K in pharmaceutical |
| 10/05/2010 | US7807795 Antibodies to osteoprotegerin binding proteins |
| 10/05/2010 | US7807787 NELL-1 (Nel-like molecule-1) polypeptide for use in induction and treatment of bone formation and disorders |
| 10/05/2010 | US7807700 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| 10/05/2010 | US7807689 such as 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile, used for the treatment of breast cancer and non-insulin depepndent diabetes |
| 10/05/2010 | US7807688 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders |
| 10/05/2010 | US7807682 Pyridyl cyanoguanidine compounds |
| 10/05/2010 | US7807675 Hyaluronic acid-methotrexate conjugate |
| 10/05/2010 | US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases |
| 10/05/2010 | US7807657 comprising liquid (A) which is aqueous solution containing hyaluronic acid ester derivative and buffered to pH of 4.5 to 6.5, and liquid (B) which is aqueous solution having a buffering power that when mixed with liquid (A), the mixed liquid has a pH range from 6.8 to 7.8, kept separate from eachother |
| 10/05/2010 | US7807179 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders |
| 10/05/2010 | US7807170 Modulating an immune response in a subject by administering an effective amount of a lymphocyte differentiation factor; antiinflammatory agents |
| 10/05/2010 | US7807142 comprising interleukin-2 (IL-2); using an amino acid base sufficient to decrease aggregate formation of the polypeptide during storage of the composition, and a buffering agent ; mixture with amino acid and buffer |
| 10/05/2010 | CA2407967C Tubulin binding ligands and corresponding prodrug constructs |
| 09/30/2010 | WO2010111627A1 Implantable formulations of bisphosphonic acids |
| 09/30/2010 | WO2010111525A2 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum |
| 09/30/2010 | WO2010111240A2 Methods for treating inflammatory arthritis |
| 09/30/2010 | WO2010110479A1 Activator for peroxisome proliferator-activated receptor |
| 09/30/2010 | WO2010110440A1 Novel therapeutic agent for cognitive impairment |
| 09/30/2010 | WO2010110352A1 Process for producing carboxylic acid compound |
| 09/30/2010 | WO2010109736A1 Cartilage production promoter and prophylactic or therapeutic agent for diseases associated with cartilage damage |
| 09/30/2010 | WO2010108410A1 Use of catechin in preparation of retrovirus integrase inhibitor |
| 09/30/2010 | WO2010064792A3 Pharmaceutical compositions containing fucoidan for stimulating and activating osteogenesis |
| 09/30/2010 | WO2010034011A9 Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release |
| 09/30/2010 | US20100249376 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/30/2010 | US20100249243 Novel beta-hydroxyketones and beta-alkoxyketones with estrogenic activity |
| 09/30/2010 | US20100249218 Method to inhibit cell growth using oligonucleotides |
| 09/30/2010 | US20100249203 Compounds that inhibit trpv1 and uses thereof |
| 09/30/2010 | US20100249161 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes |
| 09/30/2010 | US20100249159 Rho-kinase inhibitors |
| 09/30/2010 | US20100249123 Novel benzamide derivatives as modulators of the follicle stimulating hormone |
| 09/30/2010 | US20100249106 Methods of Making and Using Therapeutically Active Thiophenepyrimidinone Compounds |
| 09/30/2010 | US20100249102 Heterotricyclic Metalloprotease Inhibitors |
| 09/30/2010 | US20100249100 Quinazolines useful as modulators of ion channels |
| 09/30/2010 | US20100249092 Heteroaryl compounds and uses thereof |
| 09/30/2010 | US20100249074 Benzyl-cycloalkyl sphingosine 1-phosphate receptor modulators |
| 09/30/2010 | US20100249071 Modulators of S1P and Methods of Making And Using |
| 09/30/2010 | US20100249059 Bone filling complex and method for fabricating the same |
| 09/30/2010 | US20100249034 Gfralpha3 and its uses |
| 09/30/2010 | US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses |
| 09/30/2010 | US20100249028 Oral composition |
| 09/30/2010 | US20100247651 Platelet-derived growth factor compositions and methods for the treatment of osteochondral defects |
| 09/30/2010 | US20100247640 Solid Oral Dosage Form Containing An Enhancer |
| 09/30/2010 | US20100247607 Implantable formulations of bisphosphonic acids |
| 09/30/2010 | US20100247605 Three Dimensional Cell Protector/Pore Architecture Formation for Bone and Tissue Constructs |
| 09/30/2010 | US20100247601 Repair and treatment of bone defect using cells induced by agent produced by chondrocytes capable of hypertrophication and scaffold |
| 09/30/2010 | US20100247595 Porous structures and methods of use |
| 09/30/2010 | US20100247577 Tr1 cells, mesenchymal stem cells and uses thereof |
| 09/30/2010 | US20100247540 Methods and Compositions For Modulating Angiogenesis |
| 09/30/2010 | US20100247523 Subtypes of humanized antibody against interleuken-6 receptor |
| 09/30/2010 | US20100247520 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 09/30/2010 | US20100247518 Modified proteins, designer toxins, and methods of making thereof |
| 09/30/2010 | US20100247516 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof |
| 09/30/2010 | US20100247513 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum |
| 09/30/2010 | US20100247510 agent for reducing a side effect of an anticancer drug |
| 09/30/2010 | US20100247494 Compositions of Mesenchymal Stem Cells to Regenerate Bone |
| 09/30/2010 | US20100247482 Tight junction modulator peptides for enhanced mucosal delivery of therapeutic compounds |
| 09/30/2010 | US20100247478 Method for stabilizing vertebral body architecture |
| 09/30/2010 | US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds |
| 09/30/2010 | CA2756422A1 Process for producing carboxylic acid compound |
| 09/30/2010 | CA2754416A1 Novel medicament for treating cognitive impairment |
| 09/29/2010 | EP2233571A1 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAS encoding the same |
| 09/29/2010 | EP2233561A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 09/29/2010 | EP2233486A1 Azaindoles |
| 09/29/2010 | EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation. |
| 09/29/2010 | EP2233142A1 Transdermally absorptive preparation |
| 09/29/2010 | EP2233141A1 Ppharmaceutical compositions coprising polymorphic forms of dehydroepiandrosterone |
| 09/29/2010 | EP2231676A1 (e)-n-{3-[1-(8-fluoro-11h-10-oxa-1-aza-dibenzo[a,d]-cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid |
| 09/29/2010 | EP2231660A1 Imidazo [1,2-a] pyridine compounds |
| 09/29/2010 | EP2231652A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
| 09/29/2010 | EP2231642A1 Pyrimidines as kinase inhibitors |
| 09/29/2010 | EP2231164A1 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling |
| 09/29/2010 | EP2231159A1 Method of treating arthritis |
| 09/29/2010 | EP2231139A2 Therapeutic formulations based on asiatic acid and selected salts thereof |
| 09/29/2010 | EP2231137A1 Method of modulating membrane potential of a cell |
| 09/29/2010 | EP2231136A1 Compositions comprising hydroxytyrosol and chondroitin and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 09/29/2010 | EP1450847B1 APO2 ligand/ TRAIL formulations and uses thereof |
| 09/29/2010 | EP1446136B1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 09/29/2010 | CN1970045B Externally applied Chinese medicine for treating cervical and lumbar spondylosis |
| 09/29/2010 | CN1908183B Enzymolytic hybrid peptide of native protein with endothelin antagonism |
| 09/29/2010 | CN1893963B Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 09/29/2010 | CN1872261B Drop pills of fine powder of dragons blood, and preparation method |
| 09/29/2010 | CN1695740B Composite body of fiber protein adhesive and antibiotics in use for treating infection in deep part, and application |
| 09/29/2010 | CN101849014A Chimeric PUFA polyketide synthase systems and uses thereof |
| 09/29/2010 | CN101848926A Peptide capable of binding to immunoglobulin |
| 09/29/2010 | CN101845446A Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
| 09/29/2010 | CN101843886A Medicine containing saussurea and for curing rheumatic bone disease and preparation method thereof |
| 09/29/2010 | CN101843885A Medicament for treating distention and pain in chest and hypochondrium |
| 09/29/2010 | CN101843875A Chinese medicinal preparation for treating acute soft tissue inflammation |
| 09/29/2010 | CN101843873A Muscle-nourishing bone-strengthening ointment |
| 09/29/2010 | CN101843867A Chinese medicament for treating gout |
| 09/29/2010 | CN101843848A Chinese medicinal composition for treating gout |
| 09/29/2010 | CN101843827A Chinese medicament for treating gout |
| 09/29/2010 | CN101843815A Medicated wine |